Thumb arthritis prevalence is shifting across generations, with baby boomers (ages 55-75) currently driving demand, while younger adults (ages 30-50) face rising risks due to modern lifestyles. This demographic shift is reshaping the thumb arthritis market, as businesses cater to the needs of different age groups—from surgical solutions for older patients to preventive therapies for younger ones. Understanding these trends is key to sustaining growth and meeting evolving patient expectations.

Baby boomers, the largest aging cohort globally, dominate current cases. In the U.S., 60% of thumb arthritis patients are baby boomers, and this group accounts for 55% of market revenue. These patients often seek definitive solutions like surgical joint replacement, particularly if pain interferes with daily activities (e.g., cooking, gardening). Surgical device manufacturers like [JointSurg] report a 25% increase in CMC joint replacement sales since 2021, driven by this cohort’s demand for lasting relief.

Younger adults, however, are emerging as a new risk group. Repetitive hand use—from typing to smartphone scrolling—has led to a 10% rise in thumb joint stress injuries among 30-50-year-olds in the past 5 years. Additionally, obesity rates (linked to increased joint load) are rising globally, with 39% of adults overweight in 2023, up from 35% in 2020. These trends are driving demand for preventive treatments, such as ergonomic splints and physical therapy apps. Startups like [HandHealth] have capitalized on this, offering subscription-based therapy plans tailored for tech workers, seeing a 40% user growth in 2024.

This generational divide is prompting market segmentation. Firms are now developing “age-specific” products: senior-focused surgical kits and youth-focused preventive apps. For businesses aiming to capture both segments, diversification is critical. Market Research Future’s Generational Thumb Arthritis Market Trends Report analyzes age-specific needs, product preferences, and growth areas, helping stakeholders tailor strategies to each cohort.